A Randomized Controlled Trial of Guanfacine-er for Cannabis Use Disorder
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to investigate the effect of guanfacine-ER on reductions
in cannabis use and explore its effects on impulsivity and withdrawal through a hybrid
in-person and virtual trial of treatment-seeking individuals with Cannabis Use Disorder
(CUD), and assessing the feasibility of the virtual components of the study.